Back
3 September 2026
The ITA reports that a urine sample collected during an in-competition doping control on 26 April 2026 during the 6th Asian Beach Games Sanya 2026 from athletics athlete Doston Rajabov (Uzbekistan) has returned an Adverse Analytical Finding (AAF)¹ for several prohibited substances, namely dehydrochloromethyltestosterone (DHCMT) and drostanolone metabolites as well as for octodrine.
DCHMT and drostanolone are prohibited under the World Anti-Doping Agency (WADA) prohibited list as S1.1 anabolic androgenic steroids. They are classified as non-specified substances and prohibited at all times (in- and out-of-competition). DHCMT and drostanolone are anabolic steroids which can cause rapid muscle growth.
Octodrine is prohibited under the WADA prohibited list as S6.B stimulants and as a specified substance prohibited in-competition only. Octodrine is a central nervous system stimulant that boosts alertness and energy.
The athlete accepted the consequences of his ADRV under the OCA anti-doping rules, namely the finding of the ADRV and the disqualification of his results obtained at the 6th Asian Beach Games Sanya 2026 which include his 4th place in the men’s beach athletics shot put event.
The ITA issued the sanction on behalf of the OCA in accordance with article 8.3.3 of the OCA anti-doping rules (and equivalent provision in the World Anti-Doping Code).²
The matter is considered as resolved from the perspective of the OCA and will now be transferred to World Athletics for a determination of further consequences under the World Athletics anti-doping rules.
Parties with a right of appeal may challenge the decision before the Court of Arbitration for Sport (CAS) in accordance with article 12.2 of the OCA anti-doping rules.
There will be no further comments on this case.
¹ A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a sample the presence of a prohibited substance or its metabolites or markers or evidence of the use of a prohibited method.
² When an athlete does not challenge the assertion of an ADRV and does not request a hearing, anti-doping organisations have the possibility to issue a written decision sanctioning the athlete and imposing the applicable consequences without having to refer the case to a hearing panel. This is provided in article 8.3 of the OCA anti-doping rules and article 8.3 of the World Anti-Doping Code.
